New Market in South America: Brazil
The future of Perlka® in Brazil.
Perlka® has entered one of the main fertilizer markets in the world: Brazil. In November 2020, we delivered our first container to the state of Santa Catarina.
The initial focus will be on the states of Santa Catarina, Paraná and São Paulo in the so called “Cinturões Verdes”. These are the green belts surrounding the main cities where most of the horticulture takes place and where we target crops such as Tomato, Broccoli or Cabbage. In the state of São Paulo, the first trials with a large international seed company are already running and the first reports are very promising. We are confident that Perlka® will make a major contribution to agriculture in Brazil.
About Perlka®
Calcium cyanamide is a very special fertilizer. It not only supplies the soil with nitrogen and lime but it also offers a range of other unique special effects. Many farmers insist on calcium cyanamide or PERLKA® in order to prevent yield and quality losses during increasingly tight crop rotations, or to be able to manage them properly once again. Why? – because soil hygiene is more important than ever to ensure sustainable production.
About Alzchem
AlzChem is a globally active specialty chemicals company that is predominantly among the market leaders in its fields of activity. AlzChem benefits in particular from the three very different global megatrends of sustainability, population growth and healthy aging. AlzChem products offer attractive solutions in a wide range of applications.
The company sees interesting growth prospects for itself above all in the fields of human and animal nutrition, pharmaceuticals, agriculture, fine chemicals, metallurgy and renewable energies. The broad product range includes, for example, dietary supplements, plant growth regulators and precursors for corona tests.
The company employs around 1,630 people at four production sites in Germany and Sweden, and at two sales companies in the USA and China. In 2020, AlzChem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.